Sphinx Trading’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Sphinx Trading’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$90K	–	141
2016 Q3	$90K	Buy	+10,000	New	+$71.1K	0.18%	52

Sphinx Trading's RPTP Position: Q4 2016 in Review

Sphinx Trading sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 10,000 shares — an estimated $90K sold.

Sphinx Trading first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $90K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Sphinx Trading reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Sphinx Trading sold 10,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $90K.
Sphinx Trading first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
Sphinx Trading's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $90K in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Sphinx Trading's 13F filing for Q4 2016, filed 24 Jan 2017.